Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pucotenlimab Combined With Chemotherapy (Nab-Paclitaxel + Tegafur + Carboplatin) in the Perioperative Treatment of Locally Advanced Gastroesophageal Junction Tumors, A Multi-center Prospective Study

NCT07092449 is registered in ClinicalTrials.gov with Tang-Du Hospital as lead sponsor.

NCT NCT07092449
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07092449 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pucotenlimab Combined With Chemotherapy (Nab-Paclitaxel + Tegafur + Carboplatin) in the Perioperative Treatment of Locally Advanced Gastroesophageal Junction Tumors, A Multi-center Prospective Study
Lead sponsor
Tang-Du Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 1, 2025
Completion date
December 31, 2027
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

adjuvant therapy, gastric / gastroesophageal junction adenocarcinoma, gastroesophageal junction, neoadjuvant chemoimmunotherapy